HHS invests $480 million in Cue Health to boost manufacturing of rapid coronavirus test

Date Published10/13/2020
Author NameWilliam Feuer
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Cue Health
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
City reshored to:San Diego
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredcoronavirus test, molecular test, Cue Sample Wand
What domestic positive factors made reshoring more attractive?Government Incentives, Impact on domestic economy, Other, Covid-19
Government Incentive dollar amount:$481 million
Find Reshoring Articles